TransCode Therapeutics Inc. (NASDAQ: RNAZ)
$0.55 +0.0030 ( +0.57% ) 725.7K
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat cancer through the intelligent design and effective delivery of RNA therapeutics. The company's therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian, and colon cancer, glioblastomas, and others.